David Zaccardelli's Net Worth
David Zaccardelli's net worth is estimated to be at least $22,805,840.56 as of 06/07/2025. CoreStreet's estimation of David Zaccardelli's net worth is based on their sale of stock and current holding of stock.
David Zaccardelli is CEO at Verona Pharma PLC ADR. They have executed at least 44 trades of stock as per SEC Form 4 filings. Their most recent trade was for 208,696 units of VRNA stock on 05/29/2025. Their biggest sale was on 05/29/2025 when they sold 208,696 units of Verona Pharma PLC ADR stock for $1,947,133.68. They typically trade 7 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $22,805,840.56
Most recent insider trade:
- May 29, 2025
David Zaccardelli's Insider Trading History
| Verona Pharma PLC ADR | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 29, 2025 | CEO | 208,696 | $9.33 | Sell | $1,947,133.68 |
May 28, 2025 | CEO | 157,704 | $9.30 | Sell | $1,466,647.20 |
May 27, 2025 | CEO | 33,600 | $9.53 | Sell | $320,208.00 |
April 29, 2025 | CEO | 90,360 | $8.98 | Sell | $811,432.80 |
Dec. 6, 2024 | CEO | 162,800 | $5.01 | Sell | $815,628.00 |
Dec. 4, 2024 | CEO | 67,608 | $5.00 | Sell | $338,040.00 |
Dec. 2, 2024 | CEO | 3,200 | $5.00 | Sell | $16,000.00 |
Nov. 29, 2024 | CEO | 98,888 | $5.01 | Sell | $495,428.88 |
Nov. 27, 2024 | CEO | 23,240 | $5.00 | Sell | $116,200.00 |
Nov. 11, 2024 | CEO | 2,400 | $5.00 | Sell | $12,000.00 |
Nov. 4, 2024 | CEO | 94,144 | $4.39 | Sell | $413,292.16 |
Nov. 1, 2024 | CEO | 46,888 | $4.38 | Sell | $205,369.44 |
Oct. 25, 2024 | CEO | 4,800 | $4.38 | Sell | $21,024.00 |
Oct. 23, 2024 | CEO | 16 | $4.38 | Sell | $70.08 |
Oct. 21, 2024 | CEO | 110,456 | $4.38 | Sell | $483,797.28 |
Oct. 18, 2024 | CEO | 245,784 | $4.38 | Sell | $1,076,533.92 |
Aug. 7, 2023 | CEO | 8,616 | $2.47 | Sell | $21,281.52 |
Aug. 4, 2023 | CEO | 150,000 | $2.50 | Sell | $375,000.00 |
Aug. 2, 2023 | CEO | 73,704 | $2.59 | Sell | $190,893.36 |
May 1, 2023 | CEO | 455,536 | $2.58 | Sell | $1,175,282.88 |
Feb. 1, 2023 | CEO | 432,928 | $2.56 | Sell | $1,108,295.68 |
Dec. 20, 2022 | CEO | 600,000 | $2.12 | Sell | $1,272,000.00 |
Aug. 9, 2022 | CEO | 600,000 | $1.75 | Sell | $1,050,000.00 |
Aug. 1, 2022 | CEO | 32,904 | $0.70 | Sell | $23,032.80 |
May 3, 2022 | CEO | 32,904 | $0.50 | Sell | $16,452.00 |
Feb. 3, 2022 | CEO | 52,056 | $0.73 | Sell | $38,000.88 |
Nov. 2, 2021 | CEO | 52,056 | $0.64 | Sell | $33,315.84 |
Aug. 3, 2021 | CEO | 16,000 | $0.76 | Sell | $12,160.00 |
March 1, 2021 | CEO | 43,392 | $1.14 | Sell | $49,466.88 |
| United Therapeutics Corporation | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 14, 2015 | COO | 3,250 | $185.82 | Sell | $603,915.00 |
April 9, 2015 | COO | 4,000 | $184.84 | Sell | $739,360.00 |
April 7, 2015 | COO | 4,000 | $179.34 | Sell | $717,360.00 |
April 2, 2015 | COO | 4,000 | $174.73 | Sell | $698,920.00 |
March 26, 2015 | COO | 4,000 | $167.52 | Sell | $670,080.00 |
March 24, 2015 | COO | 4,500 | $179.51 | Sell | $807,795.00 |
March 17, 2015 | COO | 4,000 | $177.34 | Sell | $709,360.00 |
Feb. 24, 2015 | COO | 1,458 | $155.16 | Sell | $226,223.28 |
Feb. 17, 2015 | COO | 4,000 | $155.14 | Sell | $620,560.00 |
Feb. 10, 2015 | COO | 4,000 | $146.68 | Sell | $586,720.00 |
Feb. 3, 2015 | COO | 4,000 | $141.99 | Sell | $567,960.00 |
Jan. 27, 2015 | COO | 4,000 | $147.19 | Sell | $588,760.00 |
Jan. 20, 2015 | COO | 4,000 | $146.48 | Sell | $585,920.00 |
Jan. 13, 2015 | COO | 3,000 | $134.71 | Sell | $404,130.00 |
Jan. 6, 2015 | COO | 3,000 | $124.93 | Sell | $374,790.00 |